Pharma
Times
Virupaksha Organics Ltd. has established itself as a trusted name in the global pharmaceutical market, specializing in the production of Fluconazole, a critical antifungal medication used to treat a wide range of fungal infections. With state-of-the-art manufacturing facilities located in Telangana, India, the company adheres to the highest standards of quality, safety, and regulatory compliance to produce high-purity Fluconazole for both domestic and international markets.
Fluconazole is widely prescribed to treat conditions like candidiasis and cryptococcal meningitis, and Virupaksha Organics’ commitment to producing this essential API ensures a reliable supply to healthcare providers worldwide. The company’s facilities are WHO-GMP, ISO 9001, and ISO 14001 certified, reflecting its dedication to maintaining excellence in manufacturing while also being environmentally conscious.
By leveraging cutting-edge technology and a robust research and development process, Virupaksha continues to meet the growing global demand for Fluconazole, ensuring that patients receive effective and affordable treatment. As part of its mission to be a research-driven pharmaceutical company, Virupaksha Organics remains a trusted partner for pharmaceutical companies around the globe, delivering high-quality APIs with a focus on customer satisfaction and sustainability.
With its expanding global footprint, Virupaksha Organics Ltd. is poised to remain at the forefront of the pharmaceutical industry, particularly in the production of vital medications like Fluconazole, helping to combat fungal infections and improve health outcomes worldwide.
Latest Update
- TGSPDCL Turns Tree Branches Into Biochar In Green Initiative
- NDA Fast-Tracking Development: Ram Mohan Naidu
- Varuna Yagam Begins at Durga Temple Seeking Rains
- HMDA Will Issue TDR Certificates: MA&UD
- APJAC to Seek CM’s Intervention on Employees’ Demands
- US-Born Citizens Gained From H1B Visas, Says Study
- Murmu Responds to Sharif's Threat in IWT
- Ex-Minister Freed on Bail
- President Approves 78 Gallantry Awards
- Rahul Sipligunj Case: Complainant Yet To Meet Cops
- Telangana: Autorickshaw Drivers Cheer ₹1.5-Lakh EV Aid
- AP Requests KRMB to Release Water For Drinking Needs Up to Oct.31
- DC IMPACT | NTCA Seeks Report On Kawal Power Connections
- Telangana: New Tastes Relegate Traditional Sweets For Weddings
- CM Revanth: No More Fee Delays and Dues
- Sangareddy bypass widened, but Nehru, Rajiv statues to choke junction again
- Over 440 NALSAR alumni condemn BCI’s directives against students
- Naidu to take APSRTC bus on August 15 to mark one year of Stree Shakti
- Kapu meeting in New Delhi: MoS Pankaj Chaudhary unveils ‘Samakhya–2026’ poster
- Military projects worth Rs 8.75 lakh crore approved in one year: Rajnath Singh
- SC to hear plea seeking regulations for CBSE digital evaluation on August 21
- Reliance, Rolls-Royce plan sovereign combat engine for India’s AMCA
- You must be tired of fighting: SC urges Kuki, Meitei groups to restore peace
- Telangana govt extends HILT policy deadline to Oct 31 amid poor industry response
- Neymar hits out at negative Santos fans after Copa Sudamericana comeback win
- Ali Mohammad, Nikhat Banu clinch singles titles at Telangana State-rank table tennis tournament
- Massive tree axed to clear convoy route for CM’s Sangareddy rally
- Kerala steps up Sabarimala preparations, expects higher pilgrim turnout
- Bank of Baroda raises USD 700 million through overseas bonds
- Telangana govt gives contradictory figures on auto‑rickshaws, retrofitting costs